treating covid-19 with modified t-cells for immunocompromised patients
Published 2 years ago • 65 plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
4:23
impact of covid-19 on car t-cell therapies
-
1:16
the efficacy of car t-cell therapy in richter’s transformation
-
4:05
allogeneic, off-the-shelf, covid-19-specific t-cells
-
2:00
impact of covid-19 on treatment of b-cell malignancies
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
2:41
cmv treatment for stem cell transplant recipients: antivirals
-
45:50
treating persistent/chronic itp current care, future potential
-
2:31
management of all patients during covid-19
-
2:15
myeloma treatment and management in the covid era
-
2:04
autologous transplantation followed by maintenance vs maintenance alone in patients with mcl
-
1:26
the impact of covid-19 on car-t therapy
-
2:55
covid-19 & multiple myeloma: patient management
-
2:11
administering a third dose of the covid-19 vaccine to hct and car-t recipients
-
6:50
spain & covid-19: hsct, car-t and clinical practice
-
2:59
managing covid-19 risks and exposures in patients with myeloma
-
4:20
itp update: diagnosis, treatment & covid-19 vaccines
-
2:11
exploring strategies to mitigate t-cell exhaustion: treatment-free intervals & small molecules
-
10:08
treating mm patients in the covid-19 era
-
1:07
how covid-19 has impacted clinical practice and treatment approaches in multiple myeloma
-
4:34
practical strategies to reduce exposure to covid-19
-
1:56
advances in off-the-shelf third-party t-cells for the treatment of infectious diseases post-bmt